European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

Glaxosmithkline Capital plc, London

Watch
Glaxosmithkline Capital plc

If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Premium Service
Unlock Dossier
What is a Dossier?
A dossier provides comprehensive company details as a PDF, together with all underlying original publications and original data in one place.
The download feature is exclusively available for our paid plan. Upgrade your account to access:
Quick Dossier
Entire company details as a PDF
Power Dossier
Entire company details along with all original publications / original data bundled in a ZIP file
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more
Learn more
View plans

Name

Glaxosmithkline Capital plc
Smithkline Beecham Capital plc
Beecham Capital plc
Flowprice plc

Identification

Chp
Companies House 02258699
Lei
549300U0LV41VX7LEP38

Address

79 New Oxford Street, London WC1A 1DG, United Kingdom
Middlesex, United Kingdom

Corporate purpose

64.99/9
Other financial service activities, except insurance and pension funding, (not including security dealing on own account and factoring) n.e.c.

Financial performance

Earnings

For this company, Earnings numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

Revenue

For this company, Revenue numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

Total assets

For this company, Total assets numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

Taxes

For this company, Taxes numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

History

Network

Loading network

Legal Structure

Current legal representatives Legal form information Premium
Premium
2Director
1Secretary
2Director
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more View plans
Learn more View plans

JOBS AT NORTH DATA

  • Modern Java Developer
Ownership relations Premium + Ownership & Flags add-on
Premium + Ownership & Flags add-on
Shareholders and Investors
2 known active shareholders
Portfolio and Investments
One known active shareholding
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more View plans
Learn more View plans

Financials

Key Performance Indicators Financial · Mktg & Tech Premium
Premium
Base/share capital
Total assets
Earnings
Earnings CAGR
Revenue
Revenue CAGR
Return on sales
Equity
Equity ratio
Return on equity
Taxes
Tax ratio
Cash on hand
Receivables
Liabilities
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more View plans
Learn more View plans

Publications

11 Aug 2026 also 13/08/2025, 27/09/2024, 22/09/2023, 23/09/2022, 10/09/2021, 22/09/2020, 12/09/2019, 19/09/2018, 14/09/2017
Confirmation statement made with no updates
24 Jul 2026
Confirmation statement made with updates
22 May 2026
Annual report for the year ending 31/12/2025
3 Mar 2026
Director: Timothy Woodthorpe
15 Feb 2026
Statement of company's objects
28 Jan 2026
Memorandum and Articles of Association · Resolution of adoption of Articles of Association (ADOPT ARTICLES)
23 May 2025
Annual report for the year ending 31/12/2024
23 Sept 2024
Address
11 Sept 2024
Address
18 Jul 2024
Address
21 May 2024
Annual report for the year ending 31/12/2023
16 Aug 2023 also 27/09/2013
Director's details changed for Glaxo Group Limited
11 May 2023
Director: Julie Belita Brown
5 May 2023
Annual report for the year ending 31/12/2022
17 May 2022
Annual report for the year ending 31/12/2021
7 May 2021
Annual report for the year ending 31/12/2020
7 Sept 2020
Annual report for the year ending 31/12/2019
10 May 2019
Appointment of Mr Iain James Mackay as a director
7 May 2019
No longer Director: Simon Paul Dingemans
1 May 2019
Annual report for the year ending 31/12/2018
27 Jun 2018
Auditor's resignation
19 Apr 2018
Annual report for the year ending 31/12/2017
10 May 2017
Annual report for the year ending 31/12/2016
7 May 2016 also 20/05/2015, 06/05/2014, 08/05/2013, 27/04/2012, 04/05/2011, 22/06/2010, 06/04/2009, 02/05/2008, 24/04/2007, 22/03/2006, 11/04/2005
Full accounts made up to 2015-12-31
5 Oct 2015
Capital: £100,000
17 Sept 2014
Capital: £100,000
23 Apr 2014
No longer Secretary (1)
30 Sept 2013
Capital: £100,000
1 Aug 2013
Secretary (1)
2 Oct 2012 also 27/09/2011
Annual return made up to 2012-09-12 with full list of shareholders
8 Apr 2011
Director: Simon Paul Dingemans
6 Apr 2011
No longer Director (1)
15 Sept 2010
Annual return made up to 2010-09-12 with full list of shareholders · Director's details changed for Edinburgh … …
18 Sept 2009
Director (1)
15 Sept 2009 also 03/10/2008, 20/09/2007, 11/10/2006
Return made up to 12/09/09; full list of members
28 Apr 2006
Secretary's particulars changed
10 Oct 2005
Return made up to 12/09/05; full list of members · Director's particulars changed
15 Jul 2005
Interim accounts made up to 2005-05-31
18 May 2005
Listing of particulars
There are no publications matching your search.

Mentions

26 Oct 2026 in Ler
Direct parent
26 Oct 2026 in Ler
Ultimate parent
30 Apr 2021 in Ler
Ultimate parent: Glaxosmithkline Investment Services Ltd
30 Apr 2021 in Ler
Ultimate parent: Glaxosmithkline Intellectual Property Ltd
12 Oct 2020 in Ler
No longer Ultimate parent: Haleon UK Services Ltd
There are no publications matching your search.

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Printing is only available to North Data premium service subscribers.